US equities
|
NVDA
$239.10
▲+0.09%
MU
$1,047.58
▼-1.54%
SPCX
$171.75
▲+0.38%
MRVL
$287.01
▲+5.81%
AMD
$649.47
▲+2.80%
INTC
$112.67
▼-3.03%
SNDK
$1,661.33
▼-2.51%
AVGO
$375.79
▲+3.66%
NVDA
$239.10
▲+0.09%
MU
$1,047.58
▼-1.54%
SPCX
$171.75
▲+0.38%
MRVL
$287.01
▲+5.81%
AMD
$649.47
▲+2.80%
INTC
$112.67
▼-3.03%
SNDK
$1,661.33
▼-2.51%
AVGO
$375.79
▲+3.66%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about cisplatin
Recent news which mentions cisplatin
Cancer 2023: What’s Happening in the Combat Zone?
July 18, 2023
Tags
chemotherapy
docetaxel
Merck (MRK)
From
Stock Gumshoe